Facebook
Twitter
LinkedIn
Forward
Advances in Hematology and Oncology Virtual Symposium
The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The Advances in Hematology and Oncology Virtual Symposium will update participants on symptom management, treatment of metastatic breast cancer, advanced urothelial cancer, tumor profiling, management of immune related adverse events, and caring for patients during a pandemic.
The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses
Learning Objectives
- Attendees will be able to identify current evidence-based practice guidelines for topic areas presented.
- Attendees will be able to identify currently available clinical trials for potential enrollment to benefit patients.
- Discuss the most current scientific and clinical research data and apply information to clinical practice.
AGENDA
8:00-8:50 AM Advances in Advanced Urothelial Carcinoma | Deepak Kilari, MD
8:50-9:40AM HER2 and Metastatic Breast Cancer | William J. Gradishar, MD, FASCO, FACP
9:40-10:30AM Caring for Patients During the Pandemic | Laura Michaelis, MD
10:30-11:20AM Management of Immune Related Adverse Events | Jonathan Thompson, MD
11:20-12:10PM Tumor Profiling | Sue Stolz, PA-C
Guest Speakers
William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology
Professor of Medicine
Chief, Division of Hematology/Oncology
Deputy Director, Clinical Network
Robert H. Lurie Comprehensive Cancer Center Northwestern University
Speakers
Deepak Kilari, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Laura Michaelis, MD
Associate Professor
Division of Hematology and Oncology
Medical College of Wisconsin
Sue Stolz, PA-C
Physician Assistant
Division of Hematology and Oncology
Medical College of Wisconsin
Jonathan Thompson, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Planning Committee
John Burfeind, MD, Program Director
Amy Harker-Murray, MD
J. Douglas Rizzo, MD, MS
James Thomas, MD, PhD
Dan Bullock
All persons in control of content have NO relevant relationships to disclose with the exception of:
| Name | Company | Relationship |
|---|---|---|
| Jonathan Thompson, MD | AstraZeneca | Speaker |
Deepak kilari, MD | Celgene, Ipsen Bristol Myers Squibb Exelixis, Taiho Oncology Foundation Medicine Eisai, Cook Medical | Advisor |
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.
Available Credit
- 3.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.75 Hours of ParticipationHours of Participation credit.